Search
Returning search results with filters:
Remove filter for
Category: Biologic or vaccine
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 46 - 57 of 57 items.
Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity
AlertHealth professional risk communication | 2019-05-21
PrBENLYSTA (belimumab) - Increased Risk of Serious Depression, Suicidal Ideation or Behaviour, or Self-Injury
AlertHealth professional risk communication | 2019-04-04
DARZALEX (daratumumab) and Hepatitis B Virus Reactivation
AlertHealth professional risk communication | 2019-03-25
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Myositis
AlertHealth professional risk communication | 2019-03-13
LARTRUVO (olaratumab) - New clinical trial information important to prescribing decisions
AlertHealth professional risk communication | 2019-01-30
XOFIGO® (radium Ra 223 dichloride) - Increased Incidence of Fractures and Trend for Increased Deaths with XOFIGO used in combination with abiraterone and prednisone/prednisolone
AlertHealth professional risk communication | 2018-11-08
TECENTRIQ® (atezolizumab) - Risk of Immune-Related Nephritis
AlertHealth professional risk communication | 2018-09-18
Marvelon 28 birth control pills: Packages do not contain day-of-the-week stickers
AlertPublic advisory | 2018-09-11
Several GlaxoSmithKline Inc. vaccines: Potential Risk of Underdosing
AlertHealth professional risk communication | 2018-05-01
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
AlertHealth professional risk communication | 2018-03-16
Shortage of Erwinase for Injection and Replacement with UK Labelled Stock
AlertHealth professional risk communication | 2018-02-27
TECENTRIQ (atezolizumab) - Risk of Myocarditis
AlertHealth professional risk communication | 2018-02-14